[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Pages 40809-40810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18147]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2017-0166]


Information Collection: NRC Form 483, Registration Certificate--
In Vitro Testing with Byproduct Material Under General License

AGENCY: Nuclear Regulatory Commission.

ACTION: Renewal of existing information collection; request for 
comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public 
comment on the renewal of Office of Management and Budget (OMB) 
approval for an existing collection of information. The information 
collection is entitled, ``NRC Form 483, Registration Certificate--In 
Vitro Testing with Byproduct Material Under General License.'' NRC Form 
483 will be revised to update instructions and regulatory language.

DATES: Submit comments by October 27, 2017. Comments received after 
this date will be considered if it is practical to do so, but the 
Commission is able to ensure consideration only for comments received 
on or before this date.

ADDRESSES: You may submit comments by any of the following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0166. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact 
the individual listed in the FOR FURTHER INFORMATION CONTACT section of 
this document.
     Mail comments to: David Cullison, Office of the Chief 
Information Officer, Mail Stop: T-5 F53, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief 
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-

[[Page 40810]]

2084; email: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2017-0166 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0166. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC-2017-0166 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. A 
copy of the collection of information and related instructions may be 
obtained without charge by accessing ADAMS under Accession No. 
ML17128A454. The supporting statement is available in ADAMS under 
Accession No. ML17128A131.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting NRC's Clearance Officer, David Cullison, Office of the Chief 
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-415-2084; email: 
[email protected].

B. Submitting Comments

    Please include Docket ID NRC-2017-0166 in the subject line of your 
comment submission, in order to ensure that the NRC is able to make 
your comment submission available to the public in this docket.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC posts all comment submissions at http://www.regulations.gov as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Background

    In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 
Chapter 35), the NRC is requesting public comment on its intention to 
request the OMB's approval for the information collection summarized 
below:
    1. The title of the information collection: NRC Form 483, 
Registration Certificate--In Vitro Testing With Byproduct Material 
Under General License.
    2. OMB approval number: 3150-0038.
    3. Type of submission: Revision.
    4. The form number, if applicable: NRC Form 483.
    5. How often the collection is required or requested: There is a 
one-time submittal of information to receive a validated copy of NRC 
Form 483 with an assigned registration number. In addition, any changes 
in the information reported on NRC Form 483 must be reported in writing 
to the NRC within 30 days after the effective date of the change.
    6. Who will be required or asked to respond: Any physician, 
veterinarian in the practice of veterinary medicine, clinical 
laboratory or hospital which desires a general license to receive, 
acquire, possess, transfer, or use specified units of byproduct 
material in certain in vitro clinical or laboratory tests.
    7. The estimated number of annual responses: 6.
    8. The estimated number of annual respondents: 6.
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 1.10 hours.
    10. Abstract: Section 31.11 of title 10 of the Code of Federal 
Regulations (10 CFR), established a general license authorizing any 
physician, clinical laboratory, veterinarian in the practice of 
veterinary medicine, or hospital to possess certain small quantities of 
byproduct material for in vitro clinical or laboratory test not 
involving the internal or external administration of the byproduct 
material or the radiation therefrom to human beings or animals. 
Possession of byproduct material under 10 CFR 31.11 is not authorized 
until the physician, clinical laboratory, veterinarian in the practice 
of veterinary medicine, or hospital has filed NRC Form 483 and received 
from the Commission a validated copy of NRC Form 483 with a 
registration number. The licensee can use the validated copy of NRC 
Form 483 to obtain byproduct material from a specifically licensed 
supplier. The NRC incorporates this information into a database which 
is used to verify that a general licensee is authorized to receive the 
byproduct material.

III. Specific Requests for Comments

    The NRC is seeking comments that address the following questions:
    1. Is the proposed collection of information necessary for the NRC 
to properly perform its functions? Does the information have practical 
utility?
    2. Is the estimate of the burden of the information collection 
accurate?
    3. Is there a way to enhance the quality, utility, and clarity of 
the information to be collected?
    4. How can the burden of the information collection on respondents 
be minimized, including the use of automated collection techniques or 
other forms of information technology?

    Dated at Rockville, Maryland, this 23rd day of August, 2017.

    For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2017-18147 Filed 8-25-17; 8:45 am]
 BILLING CODE 7590-01-P